J 2022

Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study

SARYCHEVA, Tatyana Vladimirovna, Nadezda CAPKOVA, Andrzej PAJAK, Sofia MALYUTINA, Galina SIMONOVA et. al.

Basic information

Original name

Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study

Authors

SARYCHEVA, Tatyana Vladimirovna (250 France, belonging to the institution), Nadezda CAPKOVA, Andrzej PAJAK, Sofia MALYUTINA, Galina SIMONOVA, Abdonas TAMOSIUNAS, Martin BOBÁK (203 Czech Republic, belonging to the institution) and Hynek PIKHART (203 Czech Republic, guarantor, belonging to the institution)

Edition

Respiratory Research, ENGLAND, BMC, 2022, 1465-993X

Other information

Language

English

Type of outcome

Article in a journal

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

is not subject to a state or trade secret

References:

URL

RIV identification code

RIV/00216224:14310/22:00126377

Organization

Přírodovědecká fakulta – Repository – Repository

DOI

http://dx.doi.org/10.1186/s12931-022-02057-y

UT WoS

000803888300002

EID Scopus

2-s2.0-85131007557

Keywords in English

Forced expiratory volume in one second; Pulmonary function test; Cohort study; Mortality

Links

EF17_043/0009632, research and development project. 857487, interní kód Repo. 857560, interní kód Repo. RECETOX RI, large research infrastructures.
Changed: 12/6/2025 00:49, RNDr. Daniel Jakubík

Abstract

V originále

Background The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries. Methods This prospective population-based cohort includes men and women aged 45-69 years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002-2005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11-16 years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories. Results After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15-1.37) to severe (HR: 3.35; 95% CI 2.62-4.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14-8.56) and Lithuania (HR: 4.07, 95% CI 2.21-7.50). Conclusions Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts.
Displayed: 18/6/2025 15:24